Gallium Ga-68 Gozetotide Patent Expiration
Gallium Ga-68 Gozetotide is used for detecting prostate cancer lesions in men through positron emission tomography after radiolabeling with gallium-68. It was first introduced by Univ California Los Angeles
Gallium Ga-68 Gozetotide Patents
Given below is the list of patents protecting Gallium Ga-68 Gozetotide, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Illuccix | US11027031 | Kit for radiolabelling | Jul 28, 2035 | Telix |
Locametz | US11369590 | PSMA binding ligand-linker conjugates and methods for using | Aug 15, 2028 | Novartis |